Cardiovascular Pharmacology: Open Access

Artificial intelligence as a tool in facilitating ACS anticoagulation management

International Conference and Expo on Heart and Cardio Care

May 25, 2022 | Webinar

Hamed Bazrafshan Drissi

Cardiovascular Department, Shiraz University of Medical Sciences, Shiraz, Iran

Scientific Tracks Abstracts: Cardiovasc Pharm

Abstract:

Acute Coronary Syndrome (ACS) is the mainspring of fatal complications and mortality. The fundamental process related to ACS is the expansion of clots overlaying a cracked or damaged plaque, contributing to obstruction of vessels severely and, consequently, myocardial ischemia. The ruptured plaque consists of a sizable number of platelets originating from a thrombus; moreover, platelet accumulation and plaque rupture can trigger coagulation pathways. Artificial Intelligence (AI) is characterized as a series of algorithms leading to put effort into mimicking human intelligence. Machine-learning underlying artificial intelligence has one of the most practical techniques, titled deep learning. In the cardiovascular field of medicine, Applications of AI are machine learning approaches for diagnostic procedures and can be utilized for various purposes, including forecasting results after revascularization procedures, prediction of risk for cardiovascular diseases, novel drug objectives and cardiovascular imaging.AI has presented significant potential advantages in patients with ACS via machine learning. From diagnosis to treatment impacts to foreseeing adverse events, subsequently augmented bleeding risk and mortality rate in patients with ACS, since ACS cause endothelial dysfunction and vascular inflammation, machine learning ought to discover a fundamental spot in clinical medication and in interventional cardiology for the treatment and anticoagulation management in patients with ACS.

Biography :

I am a dedicated and caring cardiologist with about five years of experience in clinical practice, helping over 70 patients with their cardiac ailments daily, conducting research on cardiovascular disease, and treating patients accordingly. I have been working at the Shiraz University of Medical Science, teaching medical students and residents of cardiology. Proficiency in teaching clinical cardiology and serving as problem based learning (PBL) tutor at various stages in the medical program (The best attending of Shiraz Medical University at Education). I have worked as a senior researcher at the cardiovascular research Centre of Shiraz University.